Abstract
We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.
Original language | English |
---|---|
Pages (from-to) | 43-48 |
Number of pages | 6 |
Journal | Fukuoka igaku zasshi = Hukuoka acta medica |
Volume | 103 |
Issue number | 2 |
Publication status | Published - Feb 2012 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Medicine(all)